0001022505 false --09-30 Q3 0 0 0001022505 2020-10-01 2021-06-30 0001022505 2021-08-16 0001022505 2021-06-30 0001022505 2020-09-30 0001022505 2021-04-01 2021-06-30 0001022505 2020-04-01 2020-06-30 0001022505 2019-10-01 2020-06-30 0001022505 2019-09-30 0001022505 2020-06-30 0001022505 us-gaap:PreferredStockMember 2020-09-30 0001022505 us-gaap:CommonStockMember 2020-09-30 0001022505 us-gaap:TreasuryStockMember 2020-09-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001022505 us-gaap:RetainedEarningsMember 2020-09-30 0001022505 us-gaap:PreferredStockMember 2020-10-01 2021-06-30 0001022505 us-gaap:CommonStockMember 2020-10-01 2021-06-30 0001022505 us-gaap:TreasuryStockMember 2020-10-01 2021-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2021-06-30 0001022505 us-gaap:RetainedEarningsMember 2020-10-01 2021-06-30 0001022505 us-gaap:PreferredStockMember 2021-06-30 0001022505 us-gaap:CommonStockMember 2021-06-30 0001022505 us-gaap:TreasuryStockMember 2021-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001022505 us-gaap:RetainedEarningsMember 2021-06-30 0001022505 us-gaap:PreferredStockMember 2021-03-31 0001022505 us-gaap:CommonStockMember 2021-03-31 0001022505 us-gaap:TreasuryStockMember 2021-03-31 0001022505 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001022505 us-gaap:RetainedEarningsMember 2021-03-31 0001022505 2021-03-31 0001022505 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001022505 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001022505 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001022505 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001022505 us-gaap:PreferredStockMember 2019-09-30 0001022505 us-gaap:CommonStockMember 2019-09-30 0001022505 us-gaap:TreasuryStockMember 2019-09-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001022505 us-gaap:RetainedEarningsMember 2019-09-30 0001022505 us-gaap:PreferredStockMember 2019-10-01 2020-06-30 0001022505 us-gaap:CommonStockMember 2019-10-01 2020-06-30 0001022505 us-gaap:TreasuryStockMember 2019-10-01 2020-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2019-10-01 2020-06-30 0001022505 us-gaap:RetainedEarningsMember 2019-10-01 2020-06-30 0001022505 us-gaap:PreferredStockMember 2020-06-30 0001022505 us-gaap:CommonStockMember 2020-06-30 0001022505 us-gaap:TreasuryStockMember 2020-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001022505 us-gaap:RetainedEarningsMember 2020-06-30 0001022505 us-gaap:PreferredStockMember 2020-03-31 0001022505 us-gaap:CommonStockMember 2020-03-31 0001022505 us-gaap:TreasuryStockMember 2020-03-31 0001022505 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001022505 us-gaap:RetainedEarningsMember 2020-03-31 0001022505 2020-03-31 0001022505 us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001022505 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001022505 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001022505 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001022505 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001022505 CLOK:SecuritiesPurchaseAgreementMember CLOK:AccreditedInvestorsMember 2021-04-01 2021-04-16 0001022505 CLOK:SecuritiesPurchaseAgreementMember CLOK:AccreditedInvestorsMember us-gaap:WarrantMember 2021-04-16 0001022505 2021-03-28 2021-03-31 0001022505 2021-04-06 2021-04-07 0001022505 2021-04-06 2021-04-09 0001022505 2021-04-14 2021-04-16 0001022505 CLOK:WarrantAgreementsMember 2021-04-16 0001022505 CLOK:WarrantAgreementsMember 2021-04-01 2021-04-16 0001022505 CLOK:PlacementAgentAgreementMember 2021-01-10 2021-01-11 0001022505 CLOK:PlacementAgentAgreementMember us-gaap:PrivatePlacementMember 2021-01-11 0001022505 CLOK:PlacementAgentAgreementMember us-gaap:PrivatePlacementMember 2021-01-10 2021-01-11 0001022505 CLOK:PlacementAgentAgreementMember CLOK:PlacementWarrantsMember 2021-01-11 0001022505 CLOK:PlacementAgentAgreementMember CLOK:PlacementWarrantsMember 2021-01-10 2021-01-11 0001022505 CLOK:StockOptionsMember 2020-10-01 2021-06-30 0001022505 us-gaap:WarrantMember 2020-04-01 2020-06-30 0001022505 us-gaap:ConvertiblePreferredStockMember 2019-10-01 2020-06-30 0001022505 CLOK:SoundFiLLCMember 2019-10-01 2020-09-30 0001022505 CLOK:OneYearAgreementMember CLOK:SoundFiLLCMember 2018-10-01 2019-09-30 0001022505 2021-04-30 0001022505 CLOK:RobertLeBlancMember srt:MinimumMember 2017-12-01 2017-12-31 0001022505 CLOK:RobertLeBlancMember srt:MaximumMember 2017-12-01 2017-12-31 0001022505 CLOK:EricMarquezMember 2020-04-01 2020-04-30 0001022505 CLOK:SempleMarchalAndCooperLLPMember srt:MinimumMember 2019-10-30 2019-10-31 0001022505 CLOK:SempleMarchalAndCooperLLPMember srt:MaximumMember 2019-10-30 2019-10-31 0001022505 CLOK:SettlementAgreementMember CLOK:DeLaGarzaMember 2020-08-27 2020-08-28 0001022505 us-gaap:SubsequentEventMember CLOK:SettlementAgreementMember CLOK:DeLaGarzaMember 2020-10-01 2021-09-30 0001022505 srt:ScenarioForecastMember 2021-08-30 2021-09-01 0001022505 stpr:VA 2020-02-29 0001022505 stpr:VA 2020-02-01 2020-02-29 0001022505 CLOK:WilsonBoulevardIncMember 2020-10-01 2021-06-30 0001022505 CLOK:WilsonBoulevardIncMember 2020-01-01 2021-06-30 0001022505 stpr:VA CLOK:NewLeaseObligationsMember 2020-02-29 0001022505 2020-04-06 0001022505 2020-04-05 2020-04-06 0001022505 2021-01-28 2021-01-29 0001022505 CLOK:TexasCapitalBankMember 2021-04-14 2021-04-15 0001022505 us-gaap:PrivatePlacementMember 2020-10-01 2021-06-30 0001022505 us-gaap:PrivatePlacementMember 2021-06-30 0001022505 CLOK:JamesLeGankeMember us-gaap:CommonStockMember 2020-10-01 2021-06-30 0001022505 CLOK:JamesLeGankeMember 2020-10-01 2021-06-30 0001022505 CLOK:JamesLeGankeMember us-gaap:SeriesAPreferredStockMember 2020-10-01 2021-06-30 0001022505 CLOK:MichaelDeLaGarzaMember us-gaap:CommonStockMember 2019-10-01 2020-09-30 0001022505 CLOK:MichaelDeLaGarzaMember 2019-10-01 2020-09-30 0001022505 CLOK:FirstFireGlobalOpportunitiesFundLLCMember us-gaap:CommonStockMember 2020-10-01 2021-06-30 0001022505 CLOK:OmnibusEquityIncentivePlanMember srt:ScenarioForecastMember 2021-09-13 0001022505 srt:ScenarioForecastMember 2021-09-12 2021-09-13 0001022505 us-gaap:SubsequentEventMember CLOK:PulsonInvestmentCompanyLLCMember 2021-07-22 2021-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark one)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT

 

For the transition period from ___________ to ___________

 

Commission File No. 000-28745

 

 

Cipherloc Corporation

(Exact name of registrant as specified in its charter)

 

Texas   86-0837077
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

6836 Bee Cave Rd, Bldg. 1, S#279

Austin, TX

  78746
(Address of principal executive offices)   (Zip Code)

 

(512) 337-3728

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the Registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer Accelerated filer
  Non-Accelerated filer Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act). Yes ☐ No

 

As of August 16, 2021, 82,927,311 shares of the issuer’s common stock were outstanding.

 

 

 

 
 

 

CIPHERLOC CORPORATION

INDEX TO FORM 10-Q FILING

FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2021, AND 2020

TABLE OF CONTENTS

 

  PAGE
Cautionary Note about Forward-Looking Statements 1
   
PART I - FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited) 3
  Balance Sheets of June 30, 2021, and September 30, 2020 4
  Statements of Operations for the three and nine months ended June 30, 2021, and 2020 5
  Statements of Cash Flows for the nine months ended June 30, 2021, and 2020 6
  Statement of Stockholders’ Equity (Deficit) for the three and nine months ended June 30, 2021, and 2020 7
  Notes to Financial Statements 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3 Quantitative and Qualitative Disclosures About Market Risk 20
Item 4. Controls and Procedures 21
     
PART II - OTHER INFORMATION  
   
Item 1. Legal Proceedings 22
Item 1A. Risk Factors 22
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22
Item 3. Defaults Upon Senior Securities 22
Item 4. Mining Safety Disclosures 22
Item 5 Other Information 23
Item 6. Exhibits 23

 

 
Table of Contents 

 

CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to several risks, uncertainties, and assumptions, including those described and incorporated by reference in, Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q. These factors include:

 

● Statutory preemptive rights which our shareholders are provided under Texas law, our failure to comply with such rights in the past, dilution caused by the exercise of such rights, and potential penalties or liability in connection therewith, as well as our plans to terminate such rights in the future;

 

● Penalties and other amounts which may be payable for our failure to comply with the covenants in, and time periods set forth in, our March/April 2021 private offering documents, including ability to timely terminate the statutory preemptive rights which currently apply under Texas law;

 

● That we have incurred net losses since inception, our need for additional funding, the substantial doubt about our ability to continue as a going concern, and the terms of any future funding we raise;

 

● That COVID-19 has materially adversely affected our operations and may continue to have a material adverse impact on our operating results in the future;

 

● Our dependence on current management and our ability to attract and retain qualified employees;

 

● Competition for our products;

 

● Our ability to develop new products, improve current products and innovate;

 

● Unpredictability in our operating results;

 

● Our ability to retain existing licensees and add new licensees;

 

● Risks associated with data breaches, security flaws, unauthorized access to our and our customers’ (if any) and the customers of our licensees’ systems and products, hacking risks, risks of intentional disruption of our products or services, product failures and the effect of such failures and other events on our brand and operating results;

 

● Outages in third party infrastructure on which we rely;

 

● Customer defaults and delays in payment;

 

● Delays in product development, our failure to predict changes in technology, and actual or perceived defects or vulnerabilities in our products;

 

● Our ability to manage our growth;

 

● Our ability to protect our intellectual property (IP), enforce our IP rights and defend against claims that we infringed on the IP of others;

 

1
Table of Contents 

 

● Risks related to the volatile and sporadic trading of our common stock, dilution caused by future offerings, anti-dilutive rights which exist relating to our securities, over-hang, the effect of substantial sales of our common stock, the anti-dilutive rights of the Warrants as set forth in the Purchase Agreement, and additional restrictions put on the sale of our common stock because of it being a ‘penny stock’;

 

● Our compliance with various rules and regulations, penalties we may face for non-compliance, and the risk of new, more costly, or more restrictive rules and regulations;

 

● Our ability to maintain effective controls and procedures;

 

● Restrictions on our ability to issue new securities and amounts required to be paid to our CEO upon certain sales of the Company;

 

● The Board of Directors’ ability to designate blank check preferred stock without further shareholder approval;

 

● Risks associated with future acquisitions and/or with our failure to grow by acquisition; and

 

● Risks associated with pending and/or future litigation, lawsuits, and/or regulatory claims.

 

Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Considering these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

 

These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

 

2
Table of Contents 

 

PART I

FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders’ equity in conformity with accounting principles generally accepted in the United States of America. Except as disclosed herein, there has been no material change in the information disclosed in the notes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2020. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included, and all such adjustments are of a normal recurring nature. Operating results for the three and nine months ended June 30, 2021 are not necessarily indicative of the results that can be expected for the year ending September 30, 2021.

 

3
Table of Contents 

 

CIPHERLOC CORPORATION

BALANCE SHEETS

(UNAUDITED)

 

  

June 30,

2021

   September 30,
2020
 
ASSETS          
Current assets          
Cash  $6,848,508   $1,079,839 
Prepaid expenses   8,167    258,424 
Total current assets   6,856,675    1,338,263 
           
Other assets       200,000 
Operating lease ROU asset       291,140 
Total assets  $6,856,675   $1,829,403 
           
LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities          
Accounts payable and accrued liabilities  $527,939   $840,234 
Accrued compensation   26,912    10,000 
Operating lease liability – current portion       132,608 
Paycheck protection program loan – current portion       216,902 
Deferred revenue       15,417 
Total current liabilities   554,850    1,215,161 
           
Paycheck protection program loan – long term       148,528 
Operating lease liability – long-term portion       603,676 
Total liabilities   554,850    1,967,365 
           
Series A convertible preferred stock, $0.01 par value, 10,000,000 shares authorized; nil and 1,000,000 shares issued and outstanding as of June 30, 2021, and September 30, 2020, respectively       10,000 
Common stock, $0.01 par value, 681,000,000 shares authorized; 82,927,311 and 27,505,196 shares outstanding; and 96,342,125 and 40,792,510 issued as of June 30, 2021, and September 30, 2020, respectively   963,421    407,925 
Treasury stock, at cost 13,414,814 and 13,287,314 shares as of June 30, 2021, and September 30, 2020, respectively   (590,000)   (550,000)
Additional paid-in capital   76,419,164    68,420,721 
Accumulated deficit   (70,490,761)   (68,426,608)
Total stockholders’ equity (deficit)   6,301,824    (137,962)
Total liabilities and stockholders’ equity (deficit)  $6,856,675   $1,829,403 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

4
Table of Contents 

 

CIPHERLOC CORPORATION

STATEMENTS OF OPERATIONS

(UNAUDITED)

 

                             
   Three Months Ended   Nine Months Ended 
   June 30,   June 30, 
   2021   2020   2021   2020 
Revenues  $   $8,750   $15,417   $39,233 
Cost of revenues                
Gross profit       8,750    15,417    39,233 
                     
Operating expenses                    
General and administrative   197,534    833,260    1,748,398    4,114,084 
Selling and marketing       107,842    56,250    695,245 
Research and development   169,098    205,613    465,974    1,544,205 
Total operating expenses   366,632    1,146,715    2,270,622    6,353,534 
Operating loss   (366,632)   (1,137,965)   (2,255,205)   (6,314,301)
                     
Other income (expense)                    
Loss on disposal of asset       (19,778)       (19,778)
Miscellaneous income   192,052        192,052     
Interest expense   (1,000)       (1,000)    
Net loss  $(175,580)  $(1,157,743)  $(2,064,153)  $(6,334,079)
                     
Net loss per common share – basic and diluted  $(0.00)  $(0.03)  $(0.05)  $(0.16)
                     
Weighted average common shares outstanding – basic and diluted   81,076,516    40,642,953    45,408,375    40,740,105 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

5
Table of Contents 

 

CIPHERLOC CORPORATION

STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

               
   Nine Months Ended 
   June 30, 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(2,064,153)  $(6,334,079)
Adjustments to reconcile net loss to net cash flows used in operating activities:          
Depreciation       18,243 
PPP loan forgiveness   (192,052)    
Stock-based compensation   (4,400)   142,872 
Net loss on disposal of asset       19,778 
Impairment loss on ROU assets (gain on early termination of operating lease)   (441,597)   382,961 
Changes in operating assets and liabilities:          
Prepaid expenses and other   450,257    2,359 
Accounts payable and accrued liabilities   (315,842)   76,291 
Accrued compensation   16,912    (102,293)
Deferred revenue   (15,417)   (4,233)
Net cash used in operating activities   (2,566,292)   (5,798,100)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchases of fixed assets       (28,972)
Net cash used in investing activities       (28,972)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Purchase of treasury stock   (40,000)   (150,000)
Proceeds from PPA loan       365,430 
Repayment PPA loan   (173,378)    
Purchase of preferred stock   (10,000)    
Proceeds from the issuance of common stock, net of costs   8,558,339     
Net cash provided by financing activities   8,334,961    215,430 
           
INCREASE (DECREASE) IN CASH   5,768,669    (5,611,642)
CASH, BEGINNING OF PERIOD   1,079,839    7,839,472 
CASH, END OF PERIOD  $6,848,508   $2,227,830 
           
NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Capitalization of ROU asset  $   $746,125 
ST operating lease liability recorded  $   $61,264 
LT operating lease liability recorded  $   $684,861 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

6
Table of Contents 

 

CIPHERLOC CORPORATION

STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

 

             1             2     3     4     5     6 
For the Nine Months ended  Preferred Stock   Common Stock     Treasury  

 

Additional Paid-in

     Accumulated     Stockholders’ 
June 30, 2021   Shares    Amount    Shares    Amount    

Stock

    

Capital

    

Deficit

    

Equity

 
Balance at September 30, 2020   1,000,000   $10,000    40,792,510   $407,925   $(550,000)  $68,420,721   $(68,426,608)  $(137,962)
Options issued to directors & employees                       (4,400)       (4,400)
Preferred and treasury shares acquired   (1,000,000)   (10,000)           (40,000)            (50,000)
Issuance of common stock, net of issuance costs           55,549,615    555,496        8,002,843        8,558,339 
Net loss                            (2,064,153)  $(2,064,153)
Balance at June 30, 2021      $    96,342,125   $963,421   $(590,000)  $76,419,164   $(70,490,761)  $6,301,824 

  

For the Three Months ended  Preferred Stock   Common Stock     Treasury     Additional Paid-in     Accumulated     Stockholders’ 
June 30, 2021,  Shares   Amount   Shares   Amount     Stock     Capital     Deficit     Equity 
Balance at March 31, 2021      $    76,550,452   $765,504   $(590,000)  $73,640,761   $(70,315,181)  $3,501,084 
Options issued to directors & employees                        (84,055)       (84,055)
Issuance of common stock, net of issuance costs           19,791,773    197,917        2,862,458        3,060,375 
Net loss                            (175,580)  $(175,580)
Balance at June 30, 2021      $    96,342,125   $963,421   $(590,000)  $76,419,164   $(70,490,761)  $6,301,824 

  

 

For the Nine Months ended  Preferred Stock   Common Stock   Treasury   Additional Paid-in    Accumulated   Stockholders’ 
June 30, 2020  Shares   Amount   Shares   Amount   Stock   Capital   Deficit   Equity 
Balance at September 30, 2019   1,000,000   $10,000    40,792,510   $407,925   $   $68,225,825   $(61,456,533)  $7,187,217 
Options issued to directors & employees                        142,781        142,782 
Purchase of treasury stock                   (150,000)            (150,000)
Net loss                            (6,334,079)  $(6,334,079)
Balance at June 30, 2020   1,000,000   $10,000    40,792,510   $407,925   $(150,000)  $68,368,697   $(67,790,612)  $846,010 

 

For the Three Months ended  Preferred Stock   Common Stock   Treasury   Additional Paid-in    Accumulated   Stockholders’ 
June 30, 2020,  Shares   Amount   Shares   Amount   Stock   Capital   Deficit   Equity 
Balance at March 31, 2020   1,000,000   $10,000    40,792,510   $407,925   $(150,000)  $68,316,673   $(66,632,869)  $1,951,729 
Options issued to directors & employees                       52,024        52,024 
Purchase of treasury stock                                
Net loss                            (1,157,743)  $(1,157,743)
Balance at June 30, 2020   1,000,000   $10,000    40,792,510   $407,925   $(150,000)  $68,368,697   $(67,790,612)  $846,010 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

7
Table of Contents 

 

CIPHERLOC CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2021 AND 2020

(Unaudited)

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

Cipherloc Corporation (the “Company” or “Cipherloc”) was incorporated in the State of Texas on June 22, 1953, under the name “American Mortgage Company.” Effective August 27, 2014, we changed our name to “Cipherloc Corporation.” Our headquarters are located at 6836 Bee Cave Road, Building 1, S#279, Austin, Texas 78746. Our website is www.cipherloc.net.

 

Management is seeking shareholder approval at its upcoming shareholders meeting to be held on September 13, 2021, to among other things, change the Company’s state of incorporation from Texas to Delaware. The full slate of proposals is summarized under Note 8 - Subsequent Events section of this filing and are detailed in the Definitive Proxy Statement on Schedule 14A and related Amendments on file with the SEC. The Notice of Meeting and Proxy Statement may be viewed on http://annualgeneralmeetings.com/cipherloc/.

 

NOTE 2 – NEW EQUITY ISSUANCE

 

From March 31, 2021, to April 16, 2021, we entered into a Securities Purchase Agreement (the “Purchase Agreement”), with certain accredited investors (the “Purchasers”), pursuant to which the Company sold the Purchasers an aggregate of 55,549,615 (a) shares of common stock (“Offering Shares”), and (b) warrants to purchase shares of common stock of the Company (“Offering Warrants”). The Offering Shares and Offering Warrants were sold at a price of $0.18 per combined Offering Share and Offering Warrant (the “Offering Price”), which was equal to 80% of the closing sales price of the Company’s common stock on the OTCQB Market on March 30, 2021, which was the last trading day prior to the initial entry into the Purchase Agreement.

 

The sale of the Offering Shares and Offering Warrants occurred at four closings as follows:

 

Date of Closing  Shares Sold   Warrants Sold   Gross Proceeds 
March 31, 2021   35,757,942    35,757,942   $6,436,430 
April 7, 2021   7,513,893    7,513,893   $1,352,501 
April 9, 2021   8,683,336    8,683,336   $1,563,000 
April 16, 2021   3,594,444    3,594,444   $647,000 
    55,549,615    55,549,615   $9,998,931 

 

Total gross proceeds from the offering of the Offering Shares and Offering Warrants (the “Private Offering”) were approximately $10 million (as shown above) and the Private Offering is now closed.

 

Paulson Investment Company, LLC (the “Placement Agent”), served as placement agent for the Private Offering and the Company entered into a Placement Agent Agreement with the Placement Agent in connection therewith (the “Placement Agreement”, discussed below). As partial consideration for the services provided by the Placement Agent, the Company granted the Placement Agent and its assigns, warrants to purchase shares of common stock (“Placement Warrants”, discussed in greater detail below).

 

We agreed to use the proceeds from the Private Offering for working capital purposes and not to use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than (i) payment of trade payables in the ordinary course of the Company’s business and prior practices and (ii) the repayment of funds received by the Company under the “paycheck protection program” of the CARES Act), (b) for the redemption of any common stock or common stock equivalents, (c) for the settlement of any outstanding litigation, or (d) in violation of applicable regulations.

 

In connection with the Private Offering, each of our officers and directors entered into Lock-Up Agreements whereby they agreed not to sell, offer, or transfer, any of our securities which they hold for 180 days after the end of the Private Offering, subject to customary exceptions.

 

8
Table of Contents 

 

The Offering Warrants, which are evidenced by Common Stock Purchase Offering Warrants (the “Warrant Agreements”), have an exercise price of $0.36 per share (200% of the Offering Price), and may be exercised at any time from the grant date of the Offering Warrants (i.e., March 31, 2021, April 7, 2021, April 9, 2021, or April 16, 2021, as applicable), until five years thereafter. The Offering Warrants have cashless exercise rights if when exercised, a registration statement registering the shares of common stock issuable upon exercise thereof, is not effective with the Securities and Exchange Commission. The exercise of each of the Offering Warrants is subject to a beneficial ownership limitation of 4.99%, preventing such exercise by the holder(s) thereof, if such exercise would result in such holder(s) and their affiliates, exceeding ownership of 4.99% of our common stock. The Offering Warrants contain anti-dilution rights such that if we issue, or are deemed to have issued, common stock or common stock equivalents at a price less than the then exercise price of the Offering Warrants, the exercise price of the Offering Warrants is automatically reduced to such lower value, and the number of shares of common stock issuable upon exercise thereafter is adjusted proportionately so that the aggregate exercise price payable upon exercise of such Offering Warrants is the same prior to and after such reduction in exercise price.

 

Pursuant to the Registration Rights Agreement (“RR Agreement”), we agreed to file a registration statement to register the sale of the Offering Shares and the shares of common stock issuable upon exercise of the Warrants, prior to the 10th day after the end of the Private Offering (provided that the Placement Agent agreed that such 10 day period began on April 19, 2021, regardless of the actual closing date of the Private Offering), and to obtain effectiveness of such registration statement by the 60th calendar day following the date of the RR Agreement (March 31, 2021)(provided that in the event we are required to file any additional registration statements under the RR Agreement, such required effectiveness date is the 90th day after such registration statement is required to be filed), which registration statement was timely filed and was timely declared effective.

 

On January 11, 2021, we entered into a Placement Agent Agreement with the Placement Agent, pursuant to which we engaged the Placement Agent as the Company’s exclusive placement agent in connection with the Private Offering. Pursuant to the Placement Agent Agreement, we agreed to pay the Placement Agent a cash commission of 13% of the gross proceeds received in the Private Offering ($1,334,861), and to grant the Placement Agent or its assigns, a warrant to purchase 15% of the Offering Shares sold in the Private Offering (i.e., warrants to purchase 8,332,439 shares in aggregate), which were granted to the Placement Agent effective on April 16, 2021. The Placement Agent Agreement has a term expiring on August 31, 2021, and includes a three-year tail period, pursuant to which the Placement Agent is due the same fees payable in connection with the Private Offering, in the event the Company sells any securities to any investor or potential investor who received Private Offering documents as part of the Private Offering. In addition to the compensation payable upon completion of the Private Offering, we paid the Placement Agent a $35,000 cash retainer.

 

The Placement Warrants are evidenced by Purchase Warrants, have a term of 10 years (i.e., through April 16, 2031), an exercise price of $0.18 per share (the Offering Price), and cashless exercise rights. We are required to pay the Placement Agent liquidated damages of $10 per day for each $1,000 of shares not timely delivered upon the exercise of the Placement Warrants. The Placement Warrants include a weighted average anti-dilution right in the event we issue any shares of common stock or equivalents with a value less than the then exercise price.

 

Management has evaluated the warrants for derivative status and concluded the warrants are freestanding equity instruments.

 

NOTE 3 - BASIS OF PRESENTATION OF INTERIM FINANCIAL STATEMENTS

 

The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America. The accompanying interim unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In our opinion, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

 

Operating results for the three and nine months ended June 30, 2021, are not necessarily indicative of the results that may be expected for the year ending September 30, 2021. Notes to the unaudited interim financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended September 30, 2020, have been omitted; this report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended September 30, 2020, included within the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission.

 

9
Table of Contents 

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America. Significant accounting policies are as follows:

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity at the time of purchase of three months or less to be cash equivalents. At June 30, 2021, and September 30, 2020, cash includes cash on hand and cash in the bank. The balance of such accounts, at times, may exceed federally insured limits, as guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC insures these deposits up to $250,000. At June 30, 2021, $6,598,508 of the Company’s cash balance was uninsured.

 

Basic and Diluted Net Loss per Common Share

 

Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the reporting period. The weighted average number of shares is calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. Diluted earnings per share reflects the potential dilution that could occur if stock options, warrants, and other commitments to issue common stock were exercised or equity awards vest, resulting in the issuance of common stock that could share in the earnings of the Company. As of June 30, 2021, there were no preferred shares of stock outstanding and as of June 30, 2020, the Company had 1,000,000 shares of preferred stock outstanding, which were convertible into 1,500,000 shares of common stock.

 

Diluted loss per share is the same as basic loss per share during periods where net losses are incurred since the inclusion of the potential common stock equivalents would be anti-dilutive because of the net loss. During the three and nine months ended June 30, 2021, warrants to purchase 79,461,481 shares of common stock were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive. During the three and nine months ended June 30, 2020, warrants to purchase 24,216,866 shares of common stock and 1,000,000 shares of convertible preferred stock were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive.

 

Research and Development and Software Development Costs

 

The Company expenses all research and development costs, including patent and software development costs. Our research and development costs incurred for the nine months ended June 30, 2021, and 2020 were $465,974 and $1,544,205, respectively.

 

Revenue Recognition

 

The Company recognizes revenues in accordance with the provisions of Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers,” and a series of amendments which together we identify as “ASC Topic 606”.

 

Central to the new revenue recognition guidance is a five-step revenue recognition model that requires reporting entities to:

 

1. Identify the contract,
2. Identify the performance obligations of the contract,
3. Determine the transaction price of the contract,
4. Allocate the transaction price to the performance obligations, and
5. Recognize revenue.

 

The Company accounts for a promise to provide a customer with a right to access the Company’s intellectual property as a performance obligation satisfied over time because the customer will simultaneously receive and consume the benefit from the entity’s performance of providing access to its intellectual property as the performance occurs.

 

10
Table of Contents 

 

Software License Agreements

 

During the fiscal year ended September 30, 2019, the Company entered into a one-year agreement with SoundFi LLC (“SoundFi”) which automatically renews for subsequent one-year periods unless otherwise terminated by either party. Cipherloc received $25,000 from SoundFi during the year ended September 30, 2020.

 

The Company executed an annual software licensing agreement with Castle Shield during the year ended September 30, 2020, which also includes auto-renewing terms. Castle Shield made a $10,000 payment to the Company based on the terms of their agreement with Cipherloc.

 

During the nine-months ended June 30, 2021, the Company recognized $15,417 in licensing revenue from the SoundFi and Castle Shield agreements.

 

Recent Accounting Pronouncements

 

The Financial Accounting Standards Board (“FASB”) issues ASUs to amend the authoritative literature in the Accounting Standards Codification (“ASC”). There have been several ASUs to date that amend the original text of the ASCs. Other than those discussed below, the Company believes those ASUs issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2019-12 on its financial statements, which is effective for the Company in its fiscal year and interim periods beginning on October 1, 2021.

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurements (Topic 820) – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement, to modify the disclosure requirements for fair value measurements. The ASU removes certain disclosure requirements related to transfers between fair value hierarchy levels and valuation processes for Level 3 fair value measurements. It modifies certain disclosure requirements for investments in entities that calculate net asset value. It adds certain disclosure requirements regarding gains and losses for recurring Level 3 fair value measurements and unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.

 

The Company adopted ASU 2018-13 on October 1, 2020, and the adoption of this update did not have a material impact on the Company’s financial position, results of operations and cash flows.

 

In July 2017, the FASB issued ASU 2017-11—Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. ASU 2017-11 eliminates the requirement that a down round feature precludes equity classification when assessing whether an instrument is indexed to an entity’s own stock. A freestanding equity-linked financial instrument no longer would be accounted for as a derivative liability at fair value because of the existence of a down round feature. The Company has adopted ASU 2017-11 and implemented the pronouncement retrospectively. The adoption of this guidance did not have an impact on its financial statements.

 

As a result, a freestanding equity-linked financial instrument no longer would be accounted for as a derivative liability at fair value because of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS.

 

11
Table of Contents 

 

During March and April 2021, the Company issued warrants to purchase 63,882,054 shares of common stock that have anti-dilution rights that provide for adjustments in the exercise price and number of shares exercisable if there is an issuance of common stock or common stock equivalents at a lower price (down round feature).

 

NOTE 5 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Other than as set forth below, the Company is not currently involved in any litigation that it believes could have a material adverse effect on its financial condition or results of operations.

 

In December 2017, Robert LeBlanc, a disgruntled former consultant of the Company, filed a petition against the Company and Michael De La Garza, our former Chief Executive Officer and President, in the 20th Judicial District for Hays County, Texas (Cause No. 18-0005). The petition (which has been amended) alleges causes of action against us for alleged violation of the Texas Securities Act (based on the allegation that the defendants sold securities by means of untrue statements of material facts), common law fraud against Mr. De La Garza (for alleged misrepresentations alleged made by Mr. De La Garza); breach of fiduciary duty against Mr. De La Garza; breach of contract; as well as declaratory relief. Damages sought exceed $1,000,000 but are less than $10,000,000. The Company believes it has made all required payments and delivered the stock to the plaintiff and that the plaintiff’s claims are without merit. The consultant also included a claim of partial ownership of certain of the Company’s patents, which the Company believes is without merit. The case is currently being defended by the Company. The Company believes it has meritorious defenses to the allegations, and the Company intends to continue to vigorously defend against the litigation.

 

In April 2020, Eric Marquez, the former Secretary/Treasurer and Chief Financial Officer of the Company, and certain other plaintiffs, filed a lawsuit against the Company and Michael De La Garza, our former Chief Executive Officer and President, in the 20th Judicial District for Hays County, Texas (Cause No. 20-0818). The lawsuit alleges causes of action for fraud against Mr. De La Garza (for misrepresentations alleged made by Mr. De La Garza); Breach of Contract, for alleged breaches of Mr. Marquez’s employment agreement, which required the Company pay him cash and shares of stock; unjust enrichment; quantum meruit; and rescission of certain stock purchases made by certain of the plaintiffs, as well as declaratory relief and fraud. Damages sought exceed $1,000,000. The Company believes it has made all required payments and delivered the stock to the plaintiffs. The case is currently being defended by the Company. The Company believes it has meritorious defenses to the allegations, and the Company intends to continue to vigorously defend against the litigation.

 

Semple, Marchal & Cooper, LLP (“SMC”), the Company’s former independent registered auditing firm, has brought a demand for arbitration before the American Arbitration Association against the Company in October 2019, relating to amounts which SMC has alleged are due to SMC for services rendered, which amount was alleged to exceed $75,000, but to be less than $150,000. The parties entered arbitration regarding the amounts owed and subsequently entered into a Settlement Agreement and Release on April 26, 2021, to confidentially settle the matter and mutually release each other from any liabilities.

 

On August 28, 2020, the Company settled all litigation matters which had previously been pending with Michael De La Garza, a former chief executive officer of the Company. As a result of this settlement, De La Garza returned 13.1 million shares of common stock to the Company and the Company agreed to pay De La Garza $400,000 between September 30, 2020, and September 30, 2021. The Company has one remaining payment of $25,000 due, payable to De La Garza by September 1, 2021.

 

In October 2020, Ageos, LLC, a Virginia limited liability company (“Ageos”), filed a Third-Party Complaint against the Company (Third Party Case No. GV20015643-00) in connection with the pending action titled Scandium, LLC v. Ageos, LLC (Case No. GV20014313-00) in the General District Court for Fairfax County in the Commonwealth of Virginia. The action relates to an operating agreement, by and between the Company and Ageos, whereby the Company agreed to guarantee Ageos’s lease to enable the leasing of space in Fairfax County, VA. The Company subsequently terminated the agreement with Ageos and offered to take over the space as an accommodation. Ageos declined. Ageos’s third party complaint demands from the Company, among other things, all damages obtained by Scandium, LLC against Ageos; (ii) other compensatory damages in connection with certain lease payments under the lease discussed above; and (iii) pre-judgment interest. This lawsuit was subsequently settled on April 29, 2021, and the Company paid Scandium $60,000 in exchange for a release from all past, present, and future liabilities associated with the lease.

 

12
Table of Contents 

 

Leases

 

As of June 30, 2021, the Company has no financial obligations for facility lease agreements.

 

In February 2020, the Company leased approximately 3,666 square feet of office space on 2107 Wilson Boulevard, Arlington, Virginia. The lease for this facility began on February 1, 2020 and was scheduled to continue until July 31, 2025. The base annual rent was $159,471, a $100,000 security deposit was paid, and abatement of monthly rent payments was provided until August 1, 2020. The lease provided for annual rent increases of approximately 2.5%. The amount of future payments guaranteed was $741,680.

 

Tom Wilkinson, the Company’s Chairman of the Board of Directors, provides the Company the use of office space which he rents, at 6836 Bee Caves Road, Building 1, Suite 279, Austin, TX 78746 for its corporate headquarters. There is no formal lease or sublease agreement with Mr. Wilkinson and Mr. Wilkinson does not charge the Company any rental fees in connection therewith.

 

The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenant.

 

Operating Leases

 

Operating leases were included in operating lease ROU lease assets, and operating lease liabilities and operating long-term lease liabilities on the Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease expense is recognized in the period in which the obligation for those payments is incurred. Lease expense is included in general and administrative expense in the statements of operations and is reported net of lease income.

 

As a result of restructuring actions intended to conserve cash during the COVID-19 crisis, the Company stopped occupying the space in March 2020 and notified the landlord that the Company no longer needed the property and began seeking an amicable and reasonable termination of the lease agreement. On June 9, 2021, a settlement of $150,000 was reached with 2111 Wilson Boulevard, Inc. to terminate the lease effective June 2021. Following the settlement agreement with 2111 Wilson Boulevard, Inc., as discussed above, the Company does not have any operating leases as of June 30, 2021.

 

 

The early termination of the 2111 Wilson Boulevard operating lease resulted in recognizing a $441,597 gain in this reporting period due to the removal of the ROU assets and operating lease liabilities. The balance for ROU assets and liabilities at June 30, 2021 is $0 each.

 

Cash Flows

 

An initial right-of-use asset of $233,751 was recognized as a non-cash asset addition with the adoption of the new lease accounting standard. In February 2020, the Company’s lease in Arlington, Virginia added approximately $746,000 in new lease obligations. Cash paid for this lease was $80,402 for the nine months ended June 30, 2021 and is included in operating cash flows. The landlord agreed to an early termination and release from all past, present and future liabilities associated with the lease in exchange for a $150,000 one-time payment which the company made during June 2021.

 

13
Table of Contents 

 

Significant Judgments

 

There are no significant judgments.

 

Rent expense totaled $306,452 and $177,785 for the nine months ended June 30, 2021, and 2020, respectively.

 

NOTE 6 – DEBT

 

On April 6, 2020, to supplement its cash balance, the Company submitted their application for a Paycheck Protection Program (“PPP”) loan (the “SBA loan”) sponsored by the U.S. Small Business Administration in the amount of $365,430. On April 12, 2020, Company’s SBA loan application was approved, and the Company received loan proceeds on April 22, 2020. The SBA loan has an interest rate of 1% and matures on April 12, 2022.

 

Section 1106 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) provides for forgiveness of up to the full principal amount of qualifying loans guaranteed under the PPP. The PPP and loan forgiveness are intended to provide economic relief to small businesses, such as the Company, that are adversely impacted under the COVID-19 Emergency Declaration issued by President Donald J. Trump on March 13, 2020.

 

The PPP loan balance on March 31, 2021, was $365,430. The Company filed for partial loan forgiveness on January 29, 2021, which was approved in the amount of $192,052 on June 11, 2021. The staff reductions that occurred in 2020 prevented the Company from qualifying for full forgiveness of its principal balance.

 

The full principal balance of the loan, plus $1,000 of interest was set aside in an escrow account at Texas Capital Bank on April 15, 2021. Upon receipt of the partial forgiveness approval, the remaining amount of the Paycheck Protection Program Loan was repaid using funds in the escrow account and the remaining balance was returned to the Company’s operating account. The balance of the loan was $0 as of June 30, 2021.

 

NOTE 7 - STOCKHOLDERS’ EQUITY (DEFICIT)

 

The Company is authorized to issue 681,000,000 common shares and 10,000,000 preferred shares, each at a par value of $0.01 per share.

 

Common Stock

 

During the nine months ended June 30, 2021, the Company issued 55,549,615 shares of common stock pursuant to the Private Offering. Each share was priced at $0.18 and the gross proceeds from the equity issuance were $9,998,931. The proceeds net of issuance costs were $8,558,339.

 

During the nine months ended June 30, 2021, the Company came to a settlement with James LeGanke, as Trustee of Carmel Trust II and purchased back 127,500 shares of common stock and recorded such shares as Treasury Stock. Mr. LeGanke received a total payment of $50,000 as a result of the settlement. The Company attributed $40,000 of this settlement to the repurchase of common stock and the remaining $10,000 to the repurchase of Series A Preferred stock.

 

During the twelve months ended September 30, 2020, the Company came to a settlement with Michael De La Garza and purchased 13,137,757 shares of common stock held by Mr. De La Garza in consideration for $400,000 of which $300,000 was paid at the time of settlement and the remaining $100,000 paid through four quarterly payments of $25,000. The final payment will be made on September 1, 2021.

 

During the nine months ended June 30, 2020, the Company came to a settlement with First Fire Global Opportunity Fund, LLC and purchased back 149,557 shares of common stock for $150,000 and recorded such shares as Treasury Stock.

 

As of June 30, 2021, we had issued 40,792,501 common shares of which 13,414,814 are now in treasury stock. The net amount of common shares outstanding as of June 30, 2021 was 82,927,311.

 

Series A Preferred Stock

 

During the nine months ended June 30, 2021, the Company came to a settlement with James LeGanke, as Trustee of Carmel Trust II and purchased back 1,000,000 shares of Series A Preferred Stock. Mr. LeGanke received a total payment of $50,000 as a result of the settlement. The Company attributed $10,000 of this settlement to the repurchase of the Series A Preferred Stock and the remaining $40,000 to the repurchase of common stock.

 

14
Table of Contents 

 

NOTE 8 – SUBSEQUENT EVENTS

 

On July 14, 2021, we entered into an employment agreement with Nick Hnatiw to fulfill the role of Chief Technology Officer (“CTO”). The effective date of the employment agreement was June 1, 2021. Mr. Hnatiw began providing CTO services to Cipherloc as an independent contractor during November 2020.

 

On July 19, 2021, the Company filed a Definitive Proxy Statement on Schedule 14A announcing a shareholders meeting to be held on September 13, 2021 for shareholders of record as of July 15, 2021, to elect a Board of Directors and to seek approval of five other proposals. On July 28, 2021, the Definitive Proxy Statement was amended to add two additional proposals relating to executive compensation.

 

The meeting will be held at the Company’s headquarters at 6836 Bee Cave Road in Austin, Texas at 9:00 AM Central Time on September 13, 2021. Shareholders will be voting on the following proposals:

 

  1. To elect four (4) members to our Board of Directors;
     
  2. To ratify the appointment of Briggs & Veselka Co. as our independent registered public accounting firm for our fiscal year ending September 30, 2021;
     
  3. To approve the Company’s 2021 Omnibus Equity Incentive Plan and the reservation of 8,000,000 shares for issuance thereunder;
     
  4. To approve the reincorporation of the Company from the State of Texas to the State of Delaware;
     
  5. To grant discretionary authority to our board of directors to (i) amend our proposed Delaware certificate of incorporation, after the Company effectuates its reincorporation to the State of Delaware, to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of 1-for-2 to a maximum of a 1-for-20 split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders;
     
  6. To approve an amendment of the Company’s Amended and Restated Articles of Incorporation, as amended, to eliminate the shareholders’ statutory preemptive rights pursuant to Section 21.208 of the Texas Business Organizations Code in the event that the reincorporation of the Company from the State of Texas to the State of Delaware is not consummated;
     
  7. To approve, by non-binding advisory vote, of the resolution approving named executive officer compensation; and
     
  8. To approve, by non-binding advisory vote, of the frequency of future non-binding advisory votes on resolutions approving future named executive officer compensation.

 

On July 23, 2021, the “Company entered into a financial advisory and consulting agreement with Paulson Investment Company, LLC (“Paulson”). Pursuant to the agreement, Paulson will provide the following services at our request: (a) familiarize itself with our business, assets and financial condition; (b) assist us in developing strategic and financial objectives; (c) assist us in increasing our exposure in the software industry; (d) assist us in increasing our profile in the investment and financial community through introductions to analysts and potential investors, participation in investment conferences and exploitation of reasonably available media opportunities; (e) identify potentially attractive merger and acquisition opportunities; (f) review possible innovative financing opportunities and (g) render other financial advisory services as may be reasonably requested. The term of the Agreement is four years from the date of the Agreement, unless terminated earlier by either party as provided therein. As compensation for these services, we are issuing to Paulson 4,000,000 shares of our common stock and agreeing to reimburse them for all reasonable and documented expenses incurred by Paulson in connection with providing such services.

 

15
Table of Contents 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

General Information

 

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended September 30, 2020, filed with the Securities and Exchange Commission on December 29, 2020 (the “Annual Report” or the “Form 10-K”).

 

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited consolidated financial statements included above under “Part I – Financial Information” – “Item 1. Financial Statements”.

 

Our logo and some of our trademarks and tradenames are used in this Report. This Report also includes trademarks, tradenames and service marks that are the property of others. Solely for convenience, trademarks, tradenames, and service marks referred to in this Report may appear without the ®, ™ and SM symbols. References to our trademarks, tradenames and service marks are not intended to indicate in any way that we will not assert to the fullest extent under applicable law our rights or the rights of the applicable licensors if any, nor that respective owners to other intellectual property rights will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend the use or display of other companies’ trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

 

The market data and certain other statistical information used throughout this Report are based on independent industry publications, reports by market research firms or other independent sources that we believe to be reliable sources. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosures contained in this Report, and we believe these industry publications and third-party research, surveys and studies are reliable. While we are not aware of any misstatements regarding any third-party information presented in this Report, their estimates, in particular, as they relate to projections, involve numerous assumptions, are subject to risks and uncertainties, and are subject to change based on various factors, including those discussed under, and incorporated by reference in, the section entitled “Item 1A. Risk Factorsof this Report. These and other factors could cause our future performance to differ materially from our assumptions and estimates. Some market and other data included herein, as well as the data of competitors as they relate to Cipherloc Corp., is also based on our good faith estimates.

 

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “Cipherloc”, and “Cipherloc Corp.” refer specifically to Cipherloc Corp. and its consolidated subsidiaries.

 

In addition, unless the context otherwise requires and for the purposes of this report only:

 

  Exchange Act” refers to the Securities Exchange Act of 1934, as amended;
     
  SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and
     
  Securities Act” refers to the Securities Act of 1933, as amended.

 

Where You Can Find Other Information

 

We file annual, quarterly, and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at www.sec.gov and are available for download, free of charge, soon after such reports are filed with or furnished to the SEC, on the “Investor Relations,” page of our website at https://cipherloc.net. Information on our website is not part of this Report, and we do not desire to incorporate by reference such information herein. Copies of documents filed by us with the SEC are also available from us without charge, upon oral or written request to our Secretary, who can be contacted at the address and telephone number set forth on the cover page of this Report.

 

16
Table of Contents 

 

Introduction

 

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is provided in addition to the accompanying financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. MD&A is organized as follows:

 

  Business Strategy and Plan of Operations. Discussion of our strategy moving forward and how we plan to seek to increase stockholder value.
     
  Results of Operations. An analysis of our financial results comparing the three and nine months ended June 30, 2021, and 2020.

 

  Liquidity and Capital Resources. A discussion of changes in our consolidated balance sheets, cash flows and a discussion of our financial condition.
     
  Critical Accounting Policies and Estimates. Accounting estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts.

 

The following discussion should be read in conjunction with Cipherloc Corporation’s financial statements and accompanying notes included elsewhere in this Report.

 

All references to years relate to the fiscal year ended September 30 of the particular year.

 

Business Strategy and Plan of Operations

 

We are developing products and services around our patented polymorphic encryption technology designed to enable a more efficient and stronger layer of protection to be added to existing solutions. Through a licensing program, we anticipate offering the first secure commercially viable advanced “Polymorphic Encryption Core” (“PEC”) software developers kit to be used in any commercial data security industry and/or in sensitive applications.

 

As described above, our products are designed to encrypt and decrypt information. Encryption means encoding information which is readable into another form which is not readable, and which is therefore unable to be intercepted, read, or used, by someone other than the original person who encrypted the information—unless such encryption can be broken.

 

We believe that our innovative and patented polymorphic technology eliminates the flaws and inadequacies associated with today’s encryption algorithms. Instead of dealing with large monolithic blocks of data, our approach decomposes the information to be protected into multiple segments. These individual segments each have a unique encryption key, utilize different encryption algorithms, are randomly grouped into different lengths, and can be further re-encrypted. Since segments are independent from each other and are individually protected, our technology is not susceptible to computational attacks. In fact, the strength of our technology improves as compute power increases.

 

We anticipate the operating expenses for the next twelve months may require up to $7.5 million capital, which funds will come from amounts raised in the Private Offering; however, we hope to manage our business such that the existing liquidity carries the Company to positive cash flow from operations, of which there can be no assurance. This measured approach to managing cash initially emphasizes demonstrating product capabilities with current customers which is followed by a scaling exercise in all functional areas, including product development, marketing, sales, customer support, and administration. As such, the cash required for operating expenses through June 30, 2022, will most likely range from $2.4 million to $4.4 million. A summary of the operating plan by functional area is provided below.

 

Product Development will focus on further maturing the products that we have developed. Our plan is to build out our core technologies on multiple operating system platforms as well as work with current customers to ensure our product is in line with their needs. Once these items are completed, we plan to shift to further expand our product suite to enable user-defined encryption cipher modes, as well as a remote PEC management system. This will require us to expand the team footprint rapidly to ensure that we can meet market demand.

 

17
Table of Contents 

 

These efforts will require more personnel as well as more infrastructure. This personnel expansion will likely require $1 million of capital. The infrastructure needed to perform these new functions is planned to be built on modern technology with scale and reliability built from the ground-up. Utilizing cloud services, we plan to provide our customers with an interface that modern software provides, but an ease of use that encryption technologies desperately need. We believe that if we are able to meet these goals, we will be at a competitive advantage from most other players in this space. Marketing efforts will emphasize qualified lead generation using very focused industry messaging and engagement. We will be participating in relevant cybersecurity and quantum computing industry events. Our advisors will help us identify the right focus areas for lead generation. Customer support teams will need to be put in place and are expected to be built around each of our product offerings. We anticipate our Support Team will scale as our business needs change. The projected costs for the first 12 months are likely to reach $500,000. These funds will be used for salaries and technology in order for the Support Team to provide the necessary support described above. Administration requirements are currently minimal, but we expect that this will change in the event the Company is able to generate revenues and add employees. The administrative resources will be ramped according to the Company’s demand to support employees, increase accounting capacity, and expand reporting and compliance capabilities. Additional leadership personnel in accounting and human resources are anticipated to precede staff additions. We also plan to add software tools to manage functional processes.

 

Results of Operations for the three and nine months ended June 30, 2021, and 2020

 

Comparison of Results

 

Revenue decreased to zero for the three months ended June 30, 2021, from $8,750 for the three months ended June 30, 2020. Revenue decreased to $15,417 for the nine months ended June 30, 2021, from $39,233 for the nine months ended June 30, 2020. Revenues decreased due to no new invoicing activity taking place in the current reporting period. SoundFi has not been operating due to theater closures and Castle Shield did not report revenue from the PEC license agreement under which it is currently operating because it didn’t launch products until late during our third fiscal quarter (this reporting period).

 

General and administrative expenses were $197,534 and $833,260 for the three months ended June 30, 2021, and 2020, respectively. General and administrative expenses decreased primarily as a result of a gain recognized in the amount of $441,597 due to the write-off of the remaining right-of-use (ROU) assets and operating lease liability after the early termination of our final operating lease. Net of this gain, general and administrative expenses were $639,131. Compared to the same period one year ago, the current period amount reflects a decrease in headcount related costs including payroll of $93,000, due to staffing reductions initiated during the prior fiscal year, a decrease in legal fees of $146,000, due to the settlement of legal matters, decreases in board and professional fees of $51,000, and decreases in various other expenses of $13,000, offset by increases in rent of $56,000, as a result of the Virginia office lease settlement (as discussed under Note 5 – Commitments and Contingencies - Leases, to the unaudited financial statements included above) and in corporate insurance of $53,000, primarily for directors and officers liability insurance premiums.

 

General and administrative expenses were $1,748,398 and $4,114,084 for the nine months ended June 30, 2021, and 2020, respectively. The decrease in general and administrative expenses was primarily due to a decrease in legal expenses of $1,055,000 because of settlements reached during this fiscal year, a decrease in headcount related costs including payroll and travel costs of $483,000, due to staffing reductions initiated during the prior fiscal year, a $824,000 favorable variance in the accounting for ROU assets and liability ($441,597 gain in 2021 discussed above versus a $382,625 impairment loss reported during 2020), a decrease in board and professional fees of $155,000, and a decrease in various other expenses of $143,000, offset by increases in corporate insurance of $165,000, for directors and officers liability insurance premiums and rent of $129,000 related to the Virginia office lease settlement (as discussed under Note 5 – Commitments and Contingencies - Leases, to the unaudited financial statements included above).

 

18
Table of Contents 

 

Selling and marketing expenses were zero and $107,842 for the three months ended June 30, 2021, and 2020, respectively. Sales and marketing expenses decreased primarily because of a decrease in payroll expenses of $79,000, a decrease in consulting related costs of $12,000, a decrease in marketing related costs of 13,000 and a decrease in travel related costs of $4,000, all of these decreases were generated by spending reductions initiated during the prior fiscal year. We expect to resume incurring sales and marketing expenses during the fourth quarter of our fiscal year ending September 30, 2021.

 

Selling and marketing expenses were $56,250 and $695,245 for the nine months ended June 30, 2021, and 2020, respectively. Sales and marketing expenses decreased primarily because of a decrease in payroll related expenses of $323,000, a decrease in consulting related costs of $206,000, a decrease in marketed related costs of $71,000 and a decrease in travel related costs of $39,000, all of which were generated by spending reductions initiated during the prior fiscal year.

 

Research and development costs were $169,098 and $205,613 for the three months ended June 30, 2021, and 2020, respectively. Research and development costs decreased primarily because of a decrease in payroll related expenses of $26,000 and a decrease in consulting related expenses of $11,000, both decreases were the result of the spending reductions initiated during the prior fiscal year.

 

Research and development costs were $465,974 and $1,544,205 for the nine months ended June 30, 2021, and 2020, respectively. Research and development expenses decreased for the nine-month period ended June 30, 2021, primarily because of a decrease in consulting related costs of $750,000 and a decrease in payroll related expense of $329,000, both decreases were the result of the spending reductions initiated during the prior fiscal year.

 

We had a net loss of $175,580 or $0.00 per share for the three months ended June 30, 2021, compared to a net loss of $1,157,743 or $0.03 per share for the three months ended June 30, 2020. The year-over-year decrease in net loss for the three months ended June 30, was a result of a decrease in operating expenses, and the PPP loan forgiveness of $192,051. For the nine months ended June 30, 2021, we had a net loss of $2,064,153 or $0.05 per share, compared to a net loss of $6,334,079 or $0.16 per share for the nine months ended June 30, 2020. Net loss for the nine months ended June 30, decreased year-over-year as a result of the decreases in legal and other operating expenses discussed earlier.

 

Liquidity and Capital Resources

 

We had an accumulated deficit on June 30, 2021, of $70,490,761. We expect to incur substantial expenses and generate continued operating losses until we generate revenues sufficient to meet our obligations. On June 30, 2021, we had cash of $6,848,508. On March 31, 2021, we completed the initial closing of the Private Offering in which we sold 35,757,942 shares of our common stock at a price to the public of $0.18 per share, for net proceeds of $5,497,964. During the month of April 2021, we completed additional closings pursuant to the Private Offering, in which we sold 19,791,673 shares of our common stock at a price to the public of $0.18 per share, for net proceeds of $2,850,383.

 

The Private Offering is described in greater detail in Note 2 – New Equity Issuance, to the unaudited financial statements included above.

 

We had working capital of $6,301,824 as of June 30, 2021, compared to working capital of $123,102 as of September 30, 2020. Working capital increased because of funds raised through the Private Offering.

 

Cash Flows

 

The following table summarizes, for the periods indicated, selected items in our condensed Statements of Cash Flows:

 

   Nine Months Ended 
   June 30, 
   2021   2020 
Net cash provided by (used in):          
Operating activities  $(2,566,292)  $(5,798,100)
Investing activities  $   $(28,792)
Financing activities  $8,334,961   $215,430 

 

19
Table of Contents 

 

Operating Activities

 

Cash used in operating activities was $2,566,292 and $5,798,100 for the nine months ended June 30, 2021, and 2020, respectively. The uses of cash during the nine months ended June 30, 2021, were mainly attributable to a net loss of $2,064,153, which was increased by the ROU asset gain of $441,597, the PPP loan forgiveness of $192,052 and a decrease in net operating assets and liabilities of $135,910. The change in our net operating assets and liabilities was primarily due to a decrease in prepaid and other assets of $450,257, offset by a decrease in accounts payable and accrued liabilities of $298,930, and a decrease in deferred revenue of $15,417.

 

Investing Activities

 

Cash used in investing activities was zero and $28,792 for the nine months ended June 30, 2021, and 2020, respectively. The cash used in investing activities for the nine months ended June 30, 2020, was the result of fixed asset purchases.

 

Financing Activities

 

Cash provided by financing activities was $8,334,961 for the nine months ended June 30, 2021. The Company sold certain securities pursuant to the Private Offering, described in Note 2 – New Equity Issuance, to the unaudited financial statements included above, and raised $8,558,339, net of issuance costs, partially offset by the cash used in relation to a lawsuit filed by the Company against James LeGanke, as Trustee of Carmel Trust II, which was settled for $50,000 in exchange for the return of 1,000,000 shares of Series A Preferred Stock and 127,500 shares of common stock to the Company and the repayment of a portion of the PPP loan plus interest in the amount of $173,928. Cash provided in financing activities for the nine months ended June 30, 2020, was due to the proceeds from the PPP loan, offset by the legal settlement with First Fire Global Opportunity Fund, LLC and the purchase of Treasury Stock for $150,000 in connection therewith (see also Note 7 - Stockholders’ Equity (Deficit), to the unaudited financial statements included above).

 

Additional information regarding the Private Offering and the Company’s debt can be found under Note 2 – New Equity Issuance and Note 6 – Debt, to the unaudited financial statements included above.

 

Off-Balance Sheet Arrangements

 

We did not have during the periods presented, nor do we currently have, any off-balance sheet arrangements as defined under applicable SEC rules.

 

Critical Accounting Policies and Estimates

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Our management periodically evaluates the estimates and judgments made. Management bases its estimates and judgments on historical experience and on various factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates as a result of different assumptions or conditions.

 

See Note 4 of the unaudited financial statements included in “Part I—Item 1. Financial Statements”, above, for a discussion of our significant accounting policies.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), the Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

 

20
Table of Contents 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure, and is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report, at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three months ended June 30, 2021, that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting, including any corrective actions regarding significant deficiencies and material weaknesses.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

21
Table of Contents 

 

PART II

OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.

 

Such current litigation or other legal proceedings are described in, and incorporated by reference in, this “Part II - Item 1. Legal Proceedings” of this Form 10-Q from, “Part I - Item 1. Financial Statements” in the notes to financial statements in “Litigation” in Note 5 – Commitments and Contingencies. The Company believes that the resolution of currently pending matters will not individually or in the aggregate have a material adverse effect on our financial condition or results of operations. However, assessment of the current litigation or other legal claims could change in light of the discovery of facts not presently known to the Company or by judges, juries, or other finders of fact, which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or claims.

 

Additionally, the outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s financial condition and operating results for that reporting period could be materially adversely affected.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended September 30, 2020, filed with the Commission on December 29, 2020 (the “Form 10-K”), under the heading “Risk Factors” and in Part II, Item 1A of the Company’s Quarterly Report on Form 8-K for the quarter ended March 31, 2021, filed with the Commission on May 17, 2021, under the heading “Risk Factors” (the “Form 10-Q”), as supplemented by the risk factors included in the Company’s Registration on Form S-1 which was filed with the Commission on April 30, 2021 (the “Form S--1”), under the heading “Risk Factors”, except as set forth below, and investors should review the risks provided in the Form 10-K, Form 10-Q, Form S-1 and below, prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described below and in the Form 10-K, Form 10-Q and Form S-1, under the headings “Risk Factors”, which risk factors from the Form 10-K, Form 10-Q and Form S-1 are incorporated by reference in this Item 1A. Risk Factors, subject to updates to such risk factors as provided below, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Sales of Securities

 

There have been no sales of unregistered securities during the quarter ended June 30, 2021, and from the period from July 1, 2021, to the filing date of this Report, which have not previously been disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, or in a Current Report on Form 8-K.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINING SAFETY DISCLOSURES

 

Not applicable.

 

22
Table of Contents 

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

        Incorporated by Reference      

Exhibit

No.

  Description   Form   File No.   Exhibit  

Filing

Date

  Filed/Furnished Herewith  
1.1   Placement Agent Agreement dated January 11, 2021, by and between Cipherloc Corporation and Paulson Investment Company, LLC   8-K   000-28745   10.4   4/8/2021      
3.1   Articles of Incorporation of Cipherloc Corporation, as amended   S-1   333-255629   3.1   4/30/2021      
3.2   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Articles of Amendment filed by the Company with the Secretary of State of Texas on March 27, 1995   8-K   000-28745   3.1   3/5/2021      
3.3   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Articles of Correction filed by the Company with the Secretary of State on September 9, 1996   8-K   000-28745   3.2   3/5/2021      
3.4   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Articles of Amendment filed by the Company with the Secretary of State on February 28, 2001   8-K   000-28745   3.3   3/5/2021      
3.5   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Articles of Amendment filed by the Company with the Secretary of State on May 26, 2005   8-K   000-28745   3.4   3/5/2021      
3.6   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Certificate of Amendment filed by the Company with the Secretary of State on June 9, 2011   8-K   000-28745   3.5   3/5/2021      
3.7   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Certificate of Amendment filed by the Company with the Secretary of State on June 13, 2013   8-K   000-28745   3.6   3/5/2021      
3.8   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Certificate of Amendment filed by the Company with the Secretary of State on August 27, 2014   8-K   000-28745   3.7   3/5/2021      
3.9   Certificate of Correction filed with the Secretary of State of Nevada on February 8, 2021, correcting the Certificate of Amendment filed by the Company with the Secretary of State on March 26, 2018   8-K   000-28745   3.8   3/5/2021      

 

23
Table of Contents 

 

3.10   Amended and Restated Bylaws of Cipherloc Corporation   8-K   000-28745   10.5   8/30/2019      
4.1   Form of Common Stock Purchase Warrant of Cipherloc Corporation, issued in March 2021 Private Offering   8-K   000-28745   4.1   4/8/2021      
4.2   Form of Purchase Warrant Issued to Placement Agent and its Assigns dated April 16, 2021   8-K   000-28745   4.2   4/21/2021      
10.1   Settlement Agreement, effective January 15, 2021, between Cipherloc Corporation, the Carmel Trust, the Carmel Trust II, James LaGanke, individually and as Trustee of both the Trust and Trust II   8-K   000-28745   10.1   1/20/2021      
10.21   Form of Securities Purchase Agreement dated March 31, 2021, by and between Cipherloc Corporation, and each of the purchasers party thereto   8-K   000-28745   10.1   4/8/2021      
10.32   Form of Registration Rights Agreement dated March 31, 2021, by and between Cipherloc Corporation, and each of the purchasers party thereto   8-K   000-28745   10.2   4/8/2021      
10.43**   Form of Lock-Up Agreement (March 2021 Offering)   8-K   000-28745   10.3   4/8/2021      
10.5   Placement Agent Agreement dated January 11, 2021, by and between Cipherloc Corporation and Paulson Investment Company, LLC   8-K   000-28745   10.4   4/8/2021      
10.64   Indemnification Agreement dated February 22, 2021, by and between Cipherloc Corporation and Paulson Investment Company, LLC   8-K   000-28745   10.5   4/8/2021      
10.7£   March 6, 2020, Technology Partnership and Authorized Reseller Licensing Agreement between Cipherloc Corporation and ECS Federal, LLC   S-1   333-255629   10.20   4/30/2021      
10.8£   August 13, 2020, Authorized Reseller / Developer Agreement between Cipherloc Corporation and Arnouse Digital Devices   S-1   333-255629   10.21   4/30/2021      
10.5   Letter Agreement between Cipherloc Corporation and Paulson Investment Company, LLC dated July 23, 2021   8-K   000-28745   10.1   7/28/2021      
10.6   Employment Agreement with Nick Hnatiw dated July 14, 2021                   X  
31.1*   Certification of Principal Executive Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                   X  
31.2*   Certification of Principal Financial Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                   X  
32.1**   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                   X  
32.2**   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                   X  
101.INS*   Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. XBRL Instance Document                   X  

 

24
Table of Contents 

 

101.SCH*   Inline XBRL Taxonomy Extension Schema Document XBRL Taxonomy Extension Schema Document                   X  
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document XBRL Taxonomy Extension Calculation Linkbase Document                   X  
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document XBRL Taxonomy Extension Definition Linkbase Document                   X  
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document XBRL Taxonomy Extension Label Linkbase Document                   X  
101.LAB*   Inline XBRL Taxonomy Extension Presentation Linkbase Document XBRL Taxonomy Extension Presentation Linkbase Document                   X  
104*   Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set                   X  

 

* Filed herewith.
   
** Furnished herewith.
   
*** Indicates management contract or compensatory plan or arrangement.

 

25
Table of Contents 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Cipherloc Corporation
   
Date: August 16, 2021 By: /s/ David Chasteen
    David Chasteen
   

Chief Executive Officer

(Principal Executive Officer)

 

  Cipherloc Corporation
   
Date: August 16, 2021 By: /s/ Ryan Polk
    Ryan Polk
   

Chief Financial Officer

(Principal Accounting/Financial Officer)

 

26